News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,333 Results
Type
Article (15835)
Company Profile (105)
Press Release (270393)
Section
Business (92801)
Career Advice (762)
Deals (16072)
Drug Delivery (71)
Drug Development (39107)
Employer Resources (77)
FDA (6894)
Job Trends (6726)
News (159310)
Policy (15421)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Pharm Country Standard (1)
Academia (710)
Adcomms (9)
Allergies (30)
Alliances (24826)
ALS (39)
Alzheimer's disease (461)
Antibody-drug conjugate (ADC) (35)
Approvals (6909)
Artificial intelligence (102)
Autoimmune disease (5)
Automation (4)
Bankruptcy (152)
Best Places to Work (4848)
BIOSECURE Act (10)
Biosimilars (53)
Biotechnology (42)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (83)
Cancer (604)
Cardiovascular disease (57)
Career advice (646)
Career pathing (12)
CAR-T (19)
Cell therapy (87)
Cervical cancer (7)
Clinical research (32555)
Collaboration (316)
Compensation (117)
Complete response letters (17)
COVID-19 (944)
CRISPR (19)
C-suite (101)
Cystic fibrosis (43)
Data (606)
Denatured (17)
Depression (14)
Diabetes (78)
Diagnostics (1662)
Digital health (1)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (55)
Drug pricing (69)
Drug shortages (12)
Duchenne muscular dystrophy (30)
Earnings (33331)
Editorial (14)
Employer branding (7)
Employer resources (65)
Events (39867)
Executive appointments (335)
FDA (7277)
Featured Employer (23)
Friedreich's ataxia (2)
Funding (219)
Gene editing (39)
Generative AI (9)
Gene therapy (107)
GLP-1 (341)
Government (1731)
Grass and pollen (2)
Guidances (16)
Healthcare (4674)
Huntington's disease (7)
IgA nephropathy (9)
Immunology and inflammation (26)
Indications (13)
Infectious disease (979)
Inflammatory bowel disease (61)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (39)
Interviews (126)
IPO (6234)
IRA (32)
Job creations (2135)
Job search strategy (569)
Kidney cancer (6)
Labor market (7)
Layoffs (195)
Leadership (4)
Legal (3615)
Liver cancer (18)
Lung cancer (86)
Lymphoma (48)
Machine learning (1)
Management (28)
Manufacturing (138)
MASH (28)
Medical device (1992)
Medtech (1994)
Mergers & acquisitions (9997)
Metabolic disorders (237)
Multiple sclerosis (17)
NASH (14)
Neurodegenerative disease (26)
Neuropsychiatric disorders (7)
Neuroscience (641)
NextGen: Class of 2025 (1867)
Non-profit (1007)
Northern California (681)
Now hiring (7)
Obesity (134)
Opinion (138)
Ovarian cancer (19)
Pain (46)
Pancreatic cancer (13)
Parkinson's disease (47)
Partnered (6)
Patents (93)
Patient recruitment (29)
Peanut (11)
People (30017)
Pharmaceutical (65)
Pharmacy benefit managers (15)
Phase I (8677)
Phase II (13925)
Phase III (12147)
Pipeline (328)
Podcasts (46)
Policy (61)
Postmarket research (1436)
Preclinical (3530)
Press Release (30)
Prostate cancer (43)
Psychedelics (13)
Radiopharmaceuticals (123)
Rare diseases (165)
Real estate (2791)
Recruiting (31)
Regulatory (10866)
Reports (16)
Research institute (799)
Resumes & cover letters (108)
RSV (7)
Schizophrenia (33)
Series A (37)
Series B (12)
Service/supplier (4)
Sickle cell disease (33)
Southern California (695)
Special edition (6)
Sponsored (11)
Startups (1745)
State (2)
Stomach cancer (4)
Supply chain (29)
The Weekly (28)
United States (6884)
Vaccines (168)
Venture capitalists (16)
Webinars (10)
Weight loss (95)
Women's health (12)
Worklife (4)
Date
Today (72)
Last 7 days (303)
Last 30 days (1189)
Last 365 days (13607)
2025 (2315)
2024 (13763)
2023 (15555)
2022 (21571)
2021 (22287)
2020 (21913)
2019 (16956)
2018 (13386)
2017 (14929)
2016 (14152)
2015 (16582)
2014 (13270)
2013 (11230)
2012 (12010)
2011 (12527)
2010 (11342)
Location
Africa (368)
Alabama (13)
Alaska (2)
Arizona (54)
Arkansas (4)
Asia (21340)
Australia (2820)
California (1644)
Canada (870)
China (210)
Colorado (63)
Connecticut (71)
Delaware (51)
Europe (42126)
Florida (297)
Georgia (52)
Hawaii (1)
Idaho (13)
Illinois (186)
India (14)
Indiana (123)
Iowa (2)
Japan (77)
Kansas (56)
Kentucky (13)
Louisiana (1)
Maine (5)
Maryland (253)
Massachusetts (1392)
Michigan (33)
Minnesota (105)
Missouri (27)
Montana (9)
Nebraska (7)
Nevada (10)
New Hampshire (24)
New Jersey (699)
New Mexico (7)
New York (466)
North Carolina (380)
North Dakota (2)
Northern California (681)
Ohio (52)
Oklahoma (5)
Oregon (16)
Pennsylvania (401)
Puerto Rico (5)
Rhode Island (7)
South America (553)
South Carolina (3)
Southern California (695)
Tennessee (33)
Texas (224)
Utah (43)
Virginia (69)
Washington D.C. (30)
Washington State (120)
West Virginia (1)
Wisconsin (13)
286,333 Results for "essential pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
February 6, 2025
·
4 min read
Press Releases
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
March 3, 2025
·
14 min read
Press Releases
SynergenX Underscores Hormone Testing in Adults as an Essential Step Toward a Healthier New Year
February 18, 2025
·
2 min read
Drug Development
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2b clinical trial (NCT05122650) evaluating the efficacy and safety of suvecaltamide (JZP385), an investigational, highly selective and state-dependent modulator of T-type calcium channels, in adult patients with essential tremor (ET).
June 20, 2024
·
6 min read
Clinical research
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure
Biogen and Sage Therapeutics’ investigational neuroactive steroid did not significantly improve upper limb tremors in patients with essential tremor, the companies announced Wednesday.
July 24, 2024
·
2 min read
·
Tristan Manalac
Business
Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has signed a Distribution Agreement with AcedrA BioPharmaceuticals (“AcedrA”), a leading Saudi company operating in the Middle East and North Africa region.
March 26, 2024
·
4 min read
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Essential Pharma announces that it has completed the acquisition of Reminyl® oral capsules from Janssen Pharmaceutica NV, a Johnson & Johnson company.
April 17, 2024
·
3 min read
Press Releases
Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer
October 16, 2024
·
4 min read
Press Releases
Microbix Achieves Essential EU Regulatory Accreditations
October 3, 2024
·
5 min read
Deals
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd.
April 9, 2024
·
5 min read
1 of 28,634
Next
